114 In the index

Selank SEL

A calming, immune-supporting peptide developed in Russia and approved there as a nasal-spray medication. Russian studies support anxiety-easing effects, but it lacks independent Western regulatory review or large-scale confirmation.

Also known as Tuftsin analogue, Selanc, Thr-Lys-Pro-Arg-Pro-Gly-Pro, TS9JR8EP1G, RefChem:56002, TP-7, TP 7, TP-7 (diacetate)

Effects Focus Mood

Routes Nasal

Legal status Research chemical

WADA Not listed

Molecular Structure of C₃₃H₅₇N₁₁O₉

Drag to rotate · scroll to zoom

PubChem has no 3D conformer for this molecule, so this is the flat structure.

Chemistry

Formula: C33H57N11O9
Molar mass: 751.9
CAS: 129954-34-3
PubChem CID: 11765600
IUPAC name: (2S)-1-[2-[[(2S)-1-[(2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic acid
InChIKey: JTDTXGMXNXBGBZ-YVHUGQOKSA-N

Reported dosing

Limited data

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 250-500 mcg/day

Reported range 250-1000 mcg/day

Route Intranasal or subcutaneous injection

Frequency Once or twice daily

Duration 2-4 week course, often cycled

Approved and sold in Russia as an anxiolytic peptide; not FDA-approved, and independent Western confirmation of its effects is limited.

Where this comes from Russian-language clinical studies

Human data for this compound is limited. Read the figures above as a record of reported use rather than established dosing.